MARCHE SPECIFIQUE 2026 MEDICAMENTS INTERMEDIAIRE 1

Deadline:N/A

Tender information
Nord
Type
Contract award
Procedure
Other multiple stage procedure
Ref. number
MARCHE SPECIFIQUE 2026 MEDICAMENTS INTERMEDIAIRE 1
Duration
46 months
La présente consultation a pour objet la fourniture de médicaments pour le compte des établissements adhérents au GCS Pharma Hauts de France. Les caractéristiques techniques des fournitures devront répondre aux prescriptions définies par la présente lettre de consultation.

ILOPROST INJECTABLE

ILOPROST INJECTABLE

LACOSAMIDE FORME INJECTABLE

LACOSAMIDE FORME INJECTABLE

DALBAVANCINE CHLORHYDRATE

DALBAVANCINE CHLORHYDRATE

Buyer
Centre Hospitalier de Valenciennes
buyer-email@mail.com
organization number
Contract award
tenderer iconMEDIPHA SANTE SAStenderer status icon trophyAwarded

Documents

Document name
Upload date
File size
First document.pdf1 Jan 1970, 00:001 Bytes
Second document.pdf1 Jan 1970, 00:001 Bytes
Contract awarded
Important dates
31 Aug - Publication date
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.